LB Pharmaceuticals Inc (LBRX) stock
LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.06−0.24 (-0.60%)
Close on Nov 18, 2026Market cap $1.29BP/E –Yield –
LB Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
LB Pharmaceuticals's pe ratio was 0.2× on Jan 30, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 0.2× | −0.0 |
| 2025 | Dec 31, 2025 | 0.2× | – |
See a number that looks wrong?